| pubmed-article:10470190 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10470190 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
| pubmed-article:10470190 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10470190 | lifeskim:mentions | umls-concept:C0348026 | lld:lifeskim |
| pubmed-article:10470190 | lifeskim:mentions | umls-concept:C0205183 | lld:lifeskim |
| pubmed-article:10470190 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
| pubmed-article:10470190 | lifeskim:mentions | umls-concept:C0336791 | lld:lifeskim |
| pubmed-article:10470190 | pubmed:issue | 4A | lld:pubmed |
| pubmed-article:10470190 | pubmed:dateCreated | 1999-9-28 | lld:pubmed |
| pubmed-article:10470190 | pubmed:abstractText | Measurement of CA125 is well established in the diagnosis and follow-up of ovarian cancer. CA125 determination is usually performed with the monoclonal antibodies OC125 and M11. For the IMMULITE OM-MA chemoluminsence assay (DPC Biermann, Bad Nauheim, Germany) the monoclonal antibody OV185 is used. We analysed CA125 serum concentrations of patients with benign and malignant ovarian tumors with the IMMULITE OM-MA assay by defining a cut-off at 90% specificity level. Sera of 130 patients with benign and 119 patients with malignant ovarian tumors at different FIGO stages were analysed. By calculating a cut-off of 46 U/ml, in 87 ovarian cancer patients, elevated CA125 concentrations were detected (78% sensitivity). There were no significant differences between CA125 concentrations of tumors of different histological type. The measurement of CA125 by IMMULITE OM-MA is a simple and sensitive procedure. | lld:pubmed |
| pubmed-article:10470190 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10470190 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10470190 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10470190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10470190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10470190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10470190 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10470190 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10470190 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:10470190 | pubmed:author | pubmed-author:LangNN | lld:pubmed |
| pubmed-article:10470190 | pubmed:author | pubmed-author:RiegerMM | lld:pubmed |
| pubmed-article:10470190 | pubmed:author | pubmed-author:JägerWW | lld:pubmed |
| pubmed-article:10470190 | pubmed:author | pubmed-author:GebauerGG | lld:pubmed |
| pubmed-article:10470190 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10470190 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:10470190 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10470190 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10470190 | pubmed:pagination | 2535-6 | lld:pubmed |
| pubmed-article:10470190 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:meshHeading | pubmed-meshheading:10470190... | lld:pubmed |
| pubmed-article:10470190 | pubmed:articleTitle | IMMULITE OM-MA assay: a useful diagnostic tool in patients with benign and malignant ovarian tumors. | lld:pubmed |
| pubmed-article:10470190 | pubmed:affiliation | Department of Obstetrics and Gynaecology, University of Erlangen-Nuremberg, Germany. gerhard.gebauer@rzmail.uni-erlangen.de | lld:pubmed |
| pubmed-article:10470190 | pubmed:publicationType | Journal Article | lld:pubmed |
